These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 24598191)

  • 1. [Hemostatic treatment for intractable traumatic hemorrhage using fibrinogen concentrates and recombinant activated factor VII].
    Fujii T; Saito S
    Rinsho Ketsueki; 2014 Feb; 55(2):234-8. PubMed ID: 24598191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of recombinant activated factor VII in intractable bleeding during pediatric neurosurgical procedures.
    Uhrig L; Blanot S; Baugnon T; Orliaguet G; Carli PA; Meyer PG
    Pediatr Crit Care Med; 2007 Nov; 8(6):576-9. PubMed ID: 18062085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant activated Factor VII as a hemostatic agent in very low birth weight preterms with gastrointestinal hemorrhage and disseminated intravascular coagulation.
    Fischer D; Schloesser R; Buxmann H; Veldman A
    J Pediatr Hematol Oncol; 2008 May; 30(5):337-42. PubMed ID: 18458565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of recombinant factor VIIa and fibrinogen corrects clot formation in primary immune thrombocytopenia at very low platelet counts.
    Larsen OH; Stentoft J; Radia D; Ingerslev J; Sørensen B
    Br J Haematol; 2013 Jan; 160(2):228-36. PubMed ID: 23151086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the use of rFVIIa safe and effective in bleeding neonates? A retrospective series of 8 cases.
    Mitsiakos G; Papaioannou G; Giougi E; Karagianni P; Garipidou V; Nikolaidis N
    J Pediatr Hematol Oncol; 2007 Mar; 29(3):145-50. PubMed ID: 17356391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant activated factor VIIa in uncontrolled bleeding: a haemostasis laboratory study in non-haemophilia patients.
    Brandsborg S; Sørensen B; Poulsen LH; Ingerslev J
    Blood Coagul Fibrinolysis; 2006 Jun; 17(4):241-9. PubMed ID: 16651865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.
    Yilmaz D; Karapinar B; Balkan C; Akisü M; Kavakli K
    Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved clot formation by combined administration of activated factor VII (NovoSeven) and fibrinogen (Haemocomplettan P).
    Tanaka KA; Taketomi T; Szlam F; Calatzis A; Levy JH
    Anesth Analg; 2008 Mar; 106(3):732-8, table of contents. PubMed ID: 18292410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment of bleeding is to stop the bleeding! Treatment of trauma-related hemorrhage.
    Boffard KD; Choong PI; Kluger Y; Riou B; Rizoli SB; Rossaint R; Warren B;
    Transfusion; 2009 Dec; 49 Suppl 5():240S-7S. PubMed ID: 19954486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of refractory bleeding after cardiac operations with low-dose recombinant activated factor VII (NovoSeven): a propensity score analysis.
    Gelsomino S; Lorusso R; Romagnoli S; Bevilacqua S; De Cicco G; Billè G; Stefàno P; Gensini GF
    Eur J Cardiothorac Surg; 2008 Jan; 33(1):64-71. PubMed ID: 17996457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant activated factor VII: treating postoperative hemorrhage in cardiac surgery.
    Bishop CV; Renwick WE; Hogan C; Haeusler M; Tuckfield A; Tatoulis J
    Ann Thorac Surg; 2006 Mar; 81(3):875-9. PubMed ID: 16488687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant activated factor VII (NovoSeven): addition to replacement therapy in acute, uncontrolled and life-threatening bleeding.
    Mayo A; Misgav M; Kluger Y; Geenberg R; Pauzner D; Klausner J; Ben-Tal O
    Vox Sang; 2004 Jul; 87(1):34-40. PubMed ID: 15260820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel hemostatic agent: the potential role of recombinant activated factor VII (rFVIIa) in anesthetic practice.
    Murkin JM
    Can J Anaesth; 2002 Dec; 49(10):S21-6. PubMed ID: 12546007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combination of recombinant factor VIIa and fibrinogen correct clotting ex vivo in patient samples obtained following cardiopulmonary bypass surgery.
    Sørensen B; Asvaldsdottir HS; Gudmundsdottir BR; Onundarson PT
    Thromb Res; 2009 Dec; 124(6):695-700. PubMed ID: 19733387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New therapeutic possibilities for uncontrolled bleeding].
    Mikos B; Kiss K; Bolyos A; Ormay C
    Orv Hetil; 2004 Jan; 145(3):111-7. PubMed ID: 15027332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The early use of fibrinogen, prothrombin complex concentrate, and recombinant-activated factor VIIa in massive bleeding.
    Fries D
    Transfusion; 2013 Jan; 53 Suppl 1():91S-95S. PubMed ID: 23301979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of recombinant activated factor VII in traumatic nonsurgical intracranial hemorrhage.
    White CE; Schrank AE; Baskin TW; Holcomb JB
    Curr Surg; 2006; 63(5):310-7. PubMed ID: 16971200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematologic effects of recombinant factor VIIa combined with hemoglobin-based oxygen carrier-201 for prehospital resuscitation of swine with severe uncontrolled hemorrhage due to liver injury.
    Arnaud F; Hammett M; Philbin N; Scultetus A; McCarron R; Freilich D
    Blood Coagul Fibrinolysis; 2008 Oct; 19(7):669-77. PubMed ID: 18832908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged prothrombin time after recombinant activated factor VII therapy in critically bleeding trauma patients is associated with adverse outcomes.
    McMullin NR; Wade CE; Holcomb JB; Nielsen TG; Rossaint R; Riou B; Rizoli SB; Kluger Y; Choong PI; Warren B; Tortella BJ; Boffard KD;
    J Trauma; 2010 Jul; 69(1):60-9. PubMed ID: 20622579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Successful use of recombinant factor VIIa in the control of a massive bleeding in two patients with biventricular assist device (Thoratec)].
    Fritsch N; Pouquet O; Roux B; Abdelmoumen Y; Janvier G
    Ann Fr Anesth Reanim; 2010 Jan; 29(1):45-7. PubMed ID: 20080378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.